Skip to content
healthcare.dev

LAMIVUDINE and ZIDOVUDINE

NDC 43063-900, LAMIVUDINE and ZIDOVUDINE, tablet, film coated, from PD-Rx Pharmaceuticals, Inc..

Product NDC
43063-900
Status
Listed
Labeler
PD-Rx Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA079124
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43063-900 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE150 mg/1
  • ZIDOVUDINE300 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
43063-900-06430630900066 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-900-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ff62c5fc-965d-4534-a571-a4f290cb9d83

Use it

Look up 43063-900 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43063-900 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43063-900. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.